molecule comparisons, page-2

Thanks Tony, another interesting post.

nnz2256 certainly does look compelling, especially when one compares the mouse model results. Of course this doesn't mean it'll have effect in our trials, but of course it is already known to have a use in humans, do what we want it to do.

Novartis and Roche are just two of the big names interested in this. Who is going to be the first to strike a deal?

It's got to come, imho. There's too much on offer at neu, and too many big fish wanting a feed.

It's like sitting on what promises to be the biggest Uranium find, when there's a Uranium shortage and a load of big mining companies desperate for a stockpile.
Whilst the resource isn't confirmed yet, we have potentially the biggest deposit ever!
Do they (big pharma) wait for the biggest costly bun-fight ever or sign up now.

Normally they strike early.

I think a deal could happen in weeks.

all just my opinions.
cheers